维生素D3通过抑制补充和凝血级联和自途径来改善缺氧诱导的肺损伤
Chongyang Dai1, Xue Lin2, Yinglian Qi3
1Qinghai University, Xining, Qinghai Province, 810016, People's Republic of China.
BMC pulmonary medicine
|January 3, 2024
概括
在大鼠中,维生素D3 (VD3) 治疗有效地减少了因低氧引起的肺损伤. 通过抑制补充,凝血和自途径,VD3可以缓解肺.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 缺氧引起的肺损伤是一个重大的临床挑战,治疗选择有限.
- 肺代谢功能障碍有助于肺组织损伤.
- 开发新型治疗缺氧引起的肺损伤的方法至关重要.
研究的目的:
- 研究维生素D3 (VD3) 对缺氧引起的肺损伤的保护作用.
- 阐明VD3治疗作用背后的分子机制.
主要方法:
- 建立了一个小鼠缺氧模型,并用VD3进行治疗.
- 肺损伤通过H&E染色,肺水含量和透率指数进行评估.
- 用转录组分析和体外细胞模型来探索分子通路.
主要成果:
- 在暴露于缺氧的老鼠中,VD3治疗减轻了肺,炎症和透性障碍.
- VD3抑制了补充和凝血级联,由Fga和Fgb等关键基因的减少表达证明.
- 在肺细胞和组织中,VD3抑制了缺氧诱导的自.
结论:
- 维生素D3可以缓解缺氧引起的肺.
- VD3的保护作用通过抑制补充和凝血级联和自途径来介导.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Acute Respiratory Failure-V
142
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
142
Acute Respiratory Failure-II
238
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
238
Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K
Physiological Control of Respiration
2.1K
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
2.1K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
216
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
216


